注册 登录  
 加关注
   显示下一条  |  关闭
温馨提示!由于新浪微博认证机制调整,您的新浪微博帐号绑定已过期,请重新绑定!立即重新绑定新浪微博》  |  关闭

liusongjifan2的博客

读书是同智者交流;读书是对神奇世界的探访;读书是和挚友娓娓谈心 !

 
 
 

日志

 
 

【转载】Percutaneous coronary interventional strategies(The Lancet,386(9994):655–664.)  

2015-08-14 18:08:31|  分类: 医学知识 |  标签: |举报 |字号 订阅

  下载LOFTER 我的照片书  |
The Lancet— 386( 9994):655–664.—Percutaneous coronary interventional strategies - liusongjifan2 - liusongjifan2的博客
 The Lancet—Volume 386, No. 9994, p655–664, 15 August 2015
Articles

Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis

Jump to SectionIntroductionMethodsResultsDiscussionSupplementary Material

Summary

Background

Percutaneous coronary intervention (PCI) with drug-eluting stents is the standard of care for treatment of native coronary artery stenoses, but optimum treatment strategies for bare metal stent and drug-eluting stent in-stent restenosis (ISR) have not been established. We aimed to compare and rank percutaneous treatment strategies for ISR.

Methods

We did a network meta-analysis to synthesise both direct and indirect evidence from relevant trials. We searched PubMed, the Cochrane Library Central Register of Controlled Trials, and Embase for randomised controlled trials published up to Oct 31, 2014, of different PCI strategies for treatment of any type of coronary ISR. The primary outcome was percent diameter stenosis at angiographic follow-up. This study is registered with PROSPERO, number CRD42014014191.

Findings

We deemed 27 trials eligible, including 5923 patients, with follow-up ranging from 6 months to 60 months after the index intervention. Angiographic follow-up was available for 4975 (84%) of 5923 patients 6–12 months after the intervention. PCI with everolimus-eluting stents was the most effective treatment for percent diameter stenosis, with a difference of ?9·0% (95% CI ?15·8 to ?2·2) versus drug-coated balloons (DCB), ?9·4% (–17·4 to ?1·4) versus sirolimus-eluting stents, ?10·2% (–18·4 to ?2·0) versus paclitaxel-eluting stents, ?19·2% (–28·2 to ?10·4) versus vascular brachytherapy, ?23·4% (–36·2 to ?10·8) versus bare metal stents, ?24·2% (–32·2 to ?16·4) versus balloon angioplasty, and ?31·8% (–44·8 to ?18·6) versus rotablation. DCB were ranked as the second most effective treatment, but without significant differences from sirolimus-eluting (–0·2% [95% CI ?6·2 to 5·6]) or paclitaxel-eluting (–1·2% [–6·4 to 4·2]) stents.

Interpretation

These findings suggest that two strategies should be considered for treatment of any type of coronary ISR: PCI with everolimus-eluting stents because of the best angiographic and clinical outcomes, and DCB because of its ability to provide favourable results without adding a new stent layer.

Funding

None.

  评论这张
 
阅读(9)| 评论(0)
推荐 转载

历史上的今天

在LOFTER的更多文章

评论

<#--最新日志,群博日志--> <#--推荐日志--> <#--引用记录--> <#--博主推荐--> <#--随机阅读--> <#--首页推荐--> <#--历史上的今天--> <#--被推荐日志--> <#--上一篇,下一篇--> <#-- 热度 --> <#-- 网易新闻广告 --> <#--右边模块结构--> <#--评论模块结构--> <#--引用模块结构--> <#--博主发起的投票-->
 
 
 
 
 
 
 
 
 
 
 
 
 
 

页脚

网易公司版权所有 ©1997-2017